Drugs / Calcium Chloride
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | LACTATED RINGER'S IN PLASTIC CONTAINER | — | 1971-03-22 | fda.gov ↗ |
Trials 14
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03719001 | Oct 2018 → Jun 2022 | vascular disorder | University of California, San Francisco | Completed | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT03051269 | May 2016 → Dec 2018 | head and neck cancer | Rigshospitalet, Denmark | Unknown | No outcome recorded |
| Phase 1 | NCT01941914 | Aug 2013 → May 2018 | keloid | Herlev Hospital | Completed | No outcome recorded |
| Phase 1/21 trial · 1 missed | ||||||
| Phase 1/2 | NCT03867383 | Mar 2019 → Jul 2021 | uterine disorder | Stanford University | Completed | Missed primary |
| Phase 23 trials · 1 missed | ||||||
| Phase 2 | NCT07550413 | May → Nov 2026 expected | — | Pak Emirates Military Hospital | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT04153435 | Jan 2020 → Apr 2021 | cardiac arrest | Lars Wiuff Andersen | Completed | Missed primary |
| Phase 2 | NCT01941901 | Sep 2013 → Sep 2016 | — | Herlev Hospital | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT06378021 | Mar 2024 → Mar 2025 | atrial fibrillation | Helwan University | Unknown | No outcome recorded |
| Phase 3 | NCT05027048 | Apr 2022 → Mar 2023 | uterine disorder | Stanford University | Completed | No outcome recorded |
| Phase 3 | NCT05046262 | Jan 2020 → Feb 2022 | basal cell carcinoma | Bispebjerg Hospital | Unknown | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT07633600 | Jun 2026 → Jun 2027 expected | — | Jennifer Cutler | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT03772990 | Jan 2019 → Jul 2025 | cardiac valvular defect | Meshalkin Research Institute of Pathology of Circulation | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02580604 | Nov 2015 → Jul 2024 | osteoporosis | University of Colorado, Denver | Completed | No outcome recorded |
| — | NCT02213848 | Aug → Oct 2014 | curariform drugs toxicity | Seoul National University Hospital | Completed | No outcome recorded |
| Comparator or background therapy8 trials | ||||||
| Phase 0 | NCT05973747 Comparator | Aug → Dec 2023 | pregnancy disorder | Stanford University | Completed | No outcome recorded |
| Phase 2/3 | NCT05283850 Background | Feb 2022 → Feb 2027 expected | cardiac arrest | Carol Bernier | Recruiting | No outcome recorded |
| Phase 4 | NCT06494007 Comparator | Jan 2023 → Jun 2024 | atrial fibrillation, hypotensive disorder | Haseki Training and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00955266 Comparator | Jul 2009 → Feb 2010 | diastolic heart failure | Brigham and Women's Hospital | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT07187544 Comparator | Dec 2025 → Dec 2026 expected | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Recruiting | No outcome recorded |
| — | NCT06930391 Comparator | Sep 2025 → Jun 2026 overdue | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Recruiting | No outcome recorded |
| — | NCT02334475 Background | Jul 2013 → Dec 2014 | chronic pain syndrome | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
| — | NCT01839578 Background | May 2013 → Nov 2014 | infectious disease with sepsis | Hospices Civils de Lyon | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 22 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium Chloride | “single intraarticular injection of 3 ml of leukocyte free platelet rich plasma with 0.5 ml of calcium chloride(total volume 3.5 ml)” NCT02334475 ↗21“Administration of calcium chloride 5 mg/kg along with neostigmine 25 mcg/kg + atropine 15 mcg/kg” NCT02213848 ↗ “Calcium chloride in the following concentrations:1.25mM, 2.5mM and 5.0mM.” NCT06930391 ↗ “Half-normal saline IV drip and 1g IV bolus Calcium Chloride.” NCT05283850 ↗ “3.33 mL of IV calcium chloride (CaCl2, 90 mg)” NCT06494007 ↗ “Calcium chloride solution (100 mmol/L)” NCT01839578 ↗ “Calcium chloride.” NCT01941901 ↗ “Calcium Chloride” NCT07633600 ↗ |
| Known as | CaCl2 | “3.33 mL of IV calcium chloride (CaCl2, 90 mg)” NCT06494007 ↗ |
| Route | Intravenous | “Intravenous Calcium” NCT00955266 ↗ |